Pneumoconiosis

Our plain-English summary of Pneumoconiosis, by P. Cullinan, P. Reid (Primary Care Respiratory Journal, 2013).

The study

• Authors: P. Cullinan, P. Reid
• Journal: Primary Care Respiratory Journal
• Published: 2013;22(2):249-52
• Type of article: Review
• Cited by: 74 articles, as counted by NIH iCite
• Read it: PubMed · Publisher · Free full text

In plain English

This commissioned 'Perspective' article for primary care doctors reviewed pneumoconiosis, mainly asbestosis and silicosis. It reported no new research data but used two illustrative clinical scenarios. The first was a 78-year-old former power station boiler room worker whose chest X-ray showed pleural plaques and whose CT scan showed limited lung fibrosis, leading to an asbestosis diagnosis. The second was a 35-year-old stonemason with silicosis. The authors wrote that asbestosis is diagnosed when heavy occupational exposure to any type of asbestos is combined with radiological evidence of lung fibrosis. They cited the Helsinki criteria's suggested dose of at least 25 fibre/ml.years, used only as a guide because individual exposure information is rarely available. Mild cases, they stated, have a good prognosis, and there is no effective drug treatment. A high proportion of people with asbestosis die from lung cancer, they wrote, and around one in 10 develop and die from mesothelioma. They called pleural plaques benign but said the underlying exposure carries a mesothelioma risk usually around 5%. They described silicosis as invariably progressive and outlined UK compensation routes.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Narrative clinical review (commissioned 'Perspective' article) with two illustrative clinical scenarios; no original study data
• Who was studied: No study population. There were two illustrative clinical scenarios. The first was a 78-year-old man who had never been a regular smoker and who spent about 15 years in his 20s-30s working in power station boiler rooms. The second was a 35-year-old stonemason referred after routine workplace health surveillance. The article was written for UK primary care.
• Exposure: For asbestosis, occupational asbestos (any type), in occupations such as boiler lagging, asbestos textiles and the manufacture of asbestos-containing building materials. For silicosis, respirable crystalline silica (stonemasons, quarry workers, tunnellers, foundry, pottery and construction workers).
• Main results:
  • In the asbestos scenario, a chest X-ray showed several pleural plaques, some calcified, but no other abnormalities
  • In the asbestos scenario, a later thoracic CT scan identified limited bilateral lower zone fibrosis
  • In the asbestos scenario, these findings combined with the man's occupational history were considered sufficient to diagnose asbestosis
  • The authors wrote that asbestosis is diagnosed when there is heavy occupational exposure to any type of asbestos together with radiological evidence of pulmonary fibrosis
  • Citing the Helsinki criteria, the authors wrote that a dose of at least 25 fibre/ml.years is suggested as necessary to cause asbestosis
  • The authors wrote that exposure information for individual cases is rarely available, so the Helsinki value is used only as a guide
  • The authors stated that, citing other work, the incidence of and mortality from asbestosis in older UK men is still rising
  • The authors stated that the prognosis of mild asbestosis is good
  • The authors stated there is no effective drug treatment for asbestosis
  • The authors stated that a high proportion of people with asbestosis die from lung cancer
  • The authors stated that around one in 10 patients with asbestosis will develop and die from mesothelioma, about the same proportion that will die from asbestosis itself
  • The authors described pleural plaques as benign
  • For people with pleural plaques, the authors wrote that the mesothelioma risk from the underlying exposure depends partly on dose and age of exposure but is usually around 5%
  • The authors outlined several routes by which UK patients with asbestosis can claim compensation
  • In the silicosis scenario, the stonemason had no respiratory symptoms; his FEV1 fell from 5.0L (114% predicted) at age 25 to 3.3L (85% predicted) over 10 years
  • The authors stated that silicosis is invariably progressive, even after exposure stops
• The authors' conclusion: The article has no formal conclusion section. On pleural plaques, the authors wrote that the real issue is not the plaques themselves but the asbestos exposure, and its risks, that they reflect.

Topics

Medical terms in this study, explained in our Lexicon: Pneumoconiosis.

Related studies

• Pneumoconiosis: comparison of imaging and pathologic findings — S. Chong, K.S. Lee, et al. (2006)
• The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019 — J. Li, P. Yin, et al. (2022)
• Talc pneumoconiosis: a report of six patients with postmortem findings — M. Kleinfeld, C.P. Giel, et al. (1963)
• Talc pneumoconiosis — A.I. McLAUGHLIN, E. Rogers, et al. (1949)
• 24 years of pneumoconiosis mortality surveillance in Australia — D.R. Smith, P.A. Leggat (2006)
• Pneumoconiosis combined with connective tissue disease in China: a cross-sectional study — W. Xu, R. Ma, et al. (2023)

Browse return to medical research.